Toll Free: 1-888-928-9744

Acute Pain Global Clinical Trials Review, H1, 2016

Published: Apr 20, 2016 | Pages: 282 | Publisher: GlobalData | Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)

Acute Pain Global Clinical Trials Review, H1, 2016

Summary

GlobalData's clinical trial report, "Acute Pain Global Clinical Trials Review, H1, 2016" provides an overview of Acute Pain clinical trials scenario. This report provides top line data relating to the clinical trials on Acute Pain. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons To Buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
 Table of Contents
Table of Contents 2 List of Tables 3 List of Figures 4 Report Guidance 5 Clinical Trials by Region 6 Clinical Trials and Average Enrollment by Country 7 Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10 Top Five Countries Contributing to Clinical Trials in Europe 11 Top Countries Contributing to Clinical Trials in North America 12 Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13 Top Five Countries Contributing to Clinical Trials in Central and South America 14 Clinical Trials by G7 Countries: Proportion of Acute Pain to Central Nervous System Clinical Trials 15 Clinical Trials by Phase in G7 Countries 16 Clinical Trials in G7 Countries by Trial Status 17 Clinical Trials by E7 Countries: Proportion of Acute Pain to Central Nervous System Clinical Trials 18 Clinical Trials by Phase in E7 Countries 19 Clinical Trials in E7 Countries by Trial Status 20 Clinical Trials by Phase 21 In Progress Trials by Phase 22 Clinical Trials by Trial Status 23 Clinical Trials by End Point Status 24 Subjects Recruited Over a Period of Time 25 Clinical Trials by Sponsor Type 26 Prominent Sponsors 27 Top Companies Participating in Acute Pain Therapeutics Clinical Trials 28 Prominent Drugs 30 Latest Clinical Trials News on Acute Pain 31 Mar 31, 2016: OFIRMEV (Acetaminophen) Injection Health Economic Data Presented at 41st Annual Regional Anesthesiology and Acute Pain Medicine Meeting 31 Mar 14, 2016: AcelRx Pharmaceuticals Advances ARX-04 into Extension Phase of Open-Label Phase 3 Emergency Room Study 31 Mar 07, 2016: AcelRx Pharmaceuticals Initiates Phase 3 Study of ARX-04 in Patients with Post-Operative Moderate-to-Severe Acute Pain 32 Feb 25, 2016: AcelRx Pharmaceuticals Moderate-to-Severe Acute Pain Candidate ARX-04 Shows Improved Pain Scores in ER Patients in Interim Phase 3 Analysis 32 Feb 19, 2016: KemPharm to Present Data From Oral Human Abuse Liability Study for Investigational Drug KP201/APAP at the 2016 AAPM Annual Meeting 33 Feb 11, 2016: AcelRx Pharmaceuticals Presents Phase 3 Results from ARX-04 Clinical Program at JAB Burn and Wound Care Symposium 34 Jan 21, 2016: AcelRx Pharmaceuticals Announces Presentation of Phase 3 Sufentanil Sublingual 30 mcg Tablet (ARX-04) Data at the European Congress of Ambulatory Surgery 34 Clinical Trial Profile Snapshots 35 Appendix 279 Abbreviations 279 Definitions 279 Research Methodology 280 Secondary Research 280 About GlobalData 281 Contact Us 281 Disclaimer 281 Source 282
List of Tables
Acute Pain Therapeutics, Global, Clinical Trials by Region, 2016* 6 Acute Pain Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 8 Acute Pain Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 9 Acute Pain Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2016* 10 Acute Pain Therapeutics Clinical Trials, Europe, Top Five Countries, 2016* 11 Acute Pain Therapeutics Clinical Trials, North America, Top Countries, 2016* 12 Acute Pain Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2016* 13 Acute Pain Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2016* 14 Proportion of Acute Pain to Central Nervous System Clinical Trials, G7 Countries (%), 2016* 15 Acute Pain Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 16 Acute Pain Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 17 Proportion of Acute Pain to Central Nervous System Clinical Trials, E7 Countries (%), 2016* 18 Acute Pain Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 19 Acute Pain Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 20 Acute Pain Therapeutics, Global, Clinical Trials by Phase, 2016* 21 Acute Pain Therapeutics, Global, Clinical Trials In Progress by Phase 2016* 22 Acute Pain Therapeutics, Global, Clinical Trials by Trial Status, 2016* 23 Acute Pain Therapeutics Clinical Trials, Global, by End Point Status, 2016* 24 Acute Pain Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 25 Acute Pain Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016* 26 Acute Pain Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 27 Acute Pain Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 29 Acute Pain Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 30


List of Figures
Acute Pain Therapeutics, Global, Clinical Trials by Region (%), 2016* 6 Acute Pain Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7 Acute Pain Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 9 Acute Pain Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2016* 10 Acute Pain Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2016* 11 Acute Pain Therapeutics Clinical Trials, North America, Top Countries (%), 2016* 12 Acute Pain Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2016* 13 Acute Pain Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2016* 14 Proportion of Acute Pain to Central Nervous System Clinical Trials, G7 Countries (%), 2016* 15 Acute Pain Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 16 Acute Pain Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 17 Proportion of Acute Pain to Central Nervous System Clinical Trials, E7 Countries (%), 2016* 18 Acute Pain Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 19 Acute Pain Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 20 Acute Pain Therapeutics, Global, Clinical Trials by Phase (%), 2016* 21 Acute Pain Therapeutics, Global, Clinical Trials In Progress by Phase, 2016* 22 Acute Pain Therapeutics, Global, Clinical Trials by Trial Status, 2016* 23 Acute Pain Therapeutics Clinical Trials, Global, by End Point Status, 2016* 24 Acute Pain Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 25 Acute Pain Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016* 26 Acute Pain Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 27 Acute Pain Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 28 Acute Pain Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 30 GlobalData Methodology 280

To request a free sample copy of this report, please complete the form below.

This website is secure and your personal details are safe. Privacy policy

Global fumaric acid market size is anticipated to be valued at USD 764.8 million by 2020, as per a new research report by Radiant Insights, Inc. Growing processed food demand coupled with RTD (ready-to-drink) beverages consumption is expected to driv

Read More...

Global polymethyl methacrylate (PMMA) market size is likely to be valued at USD 11.65 billion by 2022; as per a new research report by Radiant Insights, Inc. Increasing spending on advertising & marketing for building strong brand equity and product

Read More...

Global contact lenses market size is estimated to reach USD 12.5 billion by 2020, according to a new industry report by Radiant Insights, Inc. Growing number of ophthalmic disorder observed in global population especially children is likely to drive

Read More...

Global geotextile market size is likely to be valued at USD 8.24 billion by 2020; as per a new research report by Radiant Insights, Inc. Increasing use in soil reinforcement activity coupled with growing application scope in road & railway developmen

Read More...

Europe industrial air filtration market size is projected to reach USD 1,690.8 million by 2020, as per a new research report by Radiant Insights, Inc. Increasing implementation in various industries such as metal, cement and food & beverages among ot

Read More...
Choose License Type
Single User - US $2500
Multi User - US $5000
Why Choose Us

24/5 Research support

Get your queries resolved from an industry expert. Request for a free product review before report purchase.

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Quality assurance

A testimonial for service excellence represented in the form of BBB "A" Accreditation.

Information security

Your personal and confidential information is safe and secure.

verify